Claim discipline

Evidence before adjectives.

A product brief is not a result. A promising ingredient list is not a clinical study. Zahara publishes a claim only after the evidence exists to support it.

Current statusPlanned validation
Macro view of translucent aqua gel-cream texture on warm ivory ceramic.

Pre-launch plan

What Zahara intends to validate.

  1. 01

    Dermatologist review

    Review formula suitability, directions, warnings, and the boundary between cosmetic and medical language.

    Planned
  2. 02

    Sensitive-skin panel

    Evaluate tolerability with the protocol, panel size, duration, and adverse events disclosed.

    Planned
  3. 03

    Comedogenicity screening

    Complete before making a non-comedogenic claim; no claim is assumed from the ingredient list alone.

    Planned
  4. 04

    Hydration and TEWL measurement

    Quantify hydration or barrier performance only when the method and observed result support it.

    Planned

Publication rule

A result should be auditable.

When validation is complete, Zahara will publish the test type, study date, sample size, duration, measured endpoint, and exact supported claim.

Until that record is live, the site will not describe Cloud Barrier Gel-Cream as clinically tested, non-comedogenic, pregnancy safe, or proven to repair a medical condition.

This standard applies to product pages, advertising, creator briefs, retailer copy, structured data, and AI-readable files.

First formula

See the brief without the overclaim.

Meet Cloud Barrier Gel-Cream